Amanta Healthcare Ltd Stock Falls to 52-Week Low of Rs 94.05

Stock Price Movement and Market Context

On the trading day, Amanta Healthcare’s shares touched an intraday low of Rs.94.05, representing a 3.83% decline from the previous close. The stock has been on a downward trajectory for four consecutive sessions, cumulatively losing 6.21% over this period. This recent slide has pushed the stock below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum.

In comparison, the Sensex opened flat but subsequently fell by 673.57 points, or 0.82%, closing at 77,565.34. The index is currently trading below its 50-day moving average, which itself is positioned below the 200-day moving average, indicating a bearish technical setup. Notably, the Sensex has declined by 6.34% over the past three weeks. Despite this, certain indices such as the NIFTY MIDCAP150 and NIFTY SMALLCAP250 reached new 52-week highs, highlighting a mixed market environment.

Financial Performance and Fundamental Assessment

Amanta Healthcare’s financial fundamentals have shown a mixed picture over recent periods. The company reported a 73.88% growth in Profit After Tax (PAT) for the nine months ending December 2025, reaching Rs.10.75 crores. Quarterly net sales also hit a record high of Rs.74.49 crores, while operating profit to interest coverage ratio peaked at 3.04 times, indicating some improvement in earnings relative to interest expenses.

However, the company’s long-term sales growth has been subdued, with a compound annual growth rate (CAGR) of -2.00% over the last five years. This negative growth trend has weighed on investor sentiment and contributed to the stock’s declining valuation. Additionally, the company’s debt servicing capacity remains a concern, with a high Debt to EBITDA ratio of 3.35 times, suggesting elevated leverage levels relative to earnings.

Valuation and Return Metrics

Despite the recent price decline, Amanta Healthcare maintains an attractive valuation on certain metrics. The company’s Return on Capital Employed (ROCE) stands at 14%, and the enterprise value to capital employed ratio is a modest 1.6 times. Over the past year, the stock’s price has remained flat, generating a 0.00% return, while profits have increased substantially by 189%. This divergence between earnings growth and stock price performance reflects market caution amid other financial and technical headwinds.

Technical Indicators and Market Sentiment

Technical analysis of Amanta Healthcare’s stock reveals predominantly bearish signals. The stock’s daily moving averages are all trending lower, and the weekly Bollinger Bands indicate a bearish stance. Dow Theory assessments on a weekly basis are mildly bearish, while monthly indicators show no clear trend in MACD, KST, or RSI. On-balance volume (OBV) data does not suggest a definitive trend, reflecting a lack of strong buying interest.

The stock’s Mojo Score currently stands at 34.0, with a Mojo Grade of Sell, downgraded from a previous Strong Sell rating on 22 Dec 2025. The Market Cap Grade is rated 4, indicating moderate market capitalisation relative to peers. These ratings underscore the cautious outlook prevailing among market participants.

Shareholding and Industry Position

Promoters remain the majority shareholders of Amanta Healthcare Ltd, maintaining significant control over the company’s strategic direction. The company operates within the Pharmaceuticals & Biotechnology sector, which has seen mixed performance recently. While some midcap and smallcap indices in the sector have reached new highs, Amanta Healthcare’s stock has lagged behind, reflecting company-specific factors rather than broad sector trends.

Summary of Key Metrics

To summarise, Amanta Healthcare Ltd’s stock has reached a new 52-week low of Rs.94.05, down from its 52-week high of Rs.154.85. The stock’s recent underperformance contrasts with the broader market’s mixed trends, including the Sensex’s 4.65% gain over the past year. The company’s financial profile shows strong profit growth in recent quarters but is tempered by negative long-term sales growth and elevated leverage ratios. Technical indicators remain predominantly bearish, and the stock trades below all major moving averages.

This combination of factors has contributed to the stock’s current valuation and market sentiment, reflected in its Mojo Grade of Sell and a subdued market capitalisation rating. Investors and analysts will continue to monitor the company’s financial results and market developments for further indications of its trajectory.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today